Kyntra Bio (KYNB) Capital Leases (2014 - 2021)
Kyntra Bio (KYNB) posted Capital Leases of $3000.0 for Q4 2021, down 40.0% sequentially from $5000.0 in Q3 2021, and down 99.99% YoY from $25.4 million in Q4 2020.
Kyntra Bio (KYNB) Capital Leases (2014 - 2021) Analysis & Trends
Kyntra Bio has reported Capital Leases for 8 years, with the latest figure at $3000.0 in Q4 2021.
- Quarterly Capital Leases fell 99.99% year-over-year to $3000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $3000.0 (down 99.99% YoY) and the FY2021 annual result came in at $3000.0, down 99.99% from the prior year.
- Capital Leases eased to $3000.0 in Q4 2021 per KYNB's latest filing, from $5000.0 in the prior quarter.
- Over five years, Capital Leases peaked at $97.8 million in Q4 2017 and troughed at $3000.0 in Q4 2021.
- A 5-year average of $50.9 million and a median of $34.5 million in 2020 frame the typical range for Capital Leases.
- The sharpest annual moves came in 2020 and 2021: Capital Leases surged 2293.97% in 2020, then sank 99.99% in 2021.
- Over 5 years, Capital Leases stood at $97.8 million in 2017, then slipped by 0.62% to $97.2 million in 2018, then tumbled by 98.72% to $1.2 million in 2019, then jumped by 1944.36% to $25.4 million in 2020, then tumbled by 99.99% to $3000.0 in 2021.
- According to Business Quant data, Capital Leases over the past three periods registered $3000.0, $5000.0, and $6000.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - |
| 10 | Kyntra Bio | 30.56 Mn | 30.56 Mn | 1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 6,000.00 |
| Mar 31, 2021 | 22.19 Mn |
| Dec 31, 2020 | 25.39 Mn |
| Mar 31, 2020 | 34.55 Mn |
| Sep 30, 2019 | 1.24 Mn |
| Jun 30, 2019 | 1.34 Mn |
| Mar 31, 2019 | 1.44 Mn |
| Dec 31, 2018 | 97.16 Mn |
| Sep 30, 2018 | 97.32 Mn |
| Jun 30, 2018 | 97.47 Mn |
| Mar 31, 2018 | 97.62 Mn |
| Dec 31, 2017 | 97.76 Mn |
| Sep 30, 2017 | 97.37 Mn |
| Jun 30, 2017 | 97.45 Mn |
| Mar 31, 2017 | 97.54 Mn |
| Dec 31, 2016 | 97.35 Mn |
| Sep 30, 2016 | 97.38 Mn |
| Jun 30, 2016 | 97.40 Mn |